Ph2 Study of EIK1001 in combo with pembro in patients with stage 4 NSCLC

Phase II Clinical Trial

A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer (EIK1001-005)

Indication: Lung Cancer
Trial Number: 06246110
Trial Status: Call Proj Mgr

Learn more about this clinical trial.

Participating Locations